Twist Bioscience (TWST) Operating Expenses (2017 - 2026)

Twist Bioscience (TWST) has 10 years of Operating Expenses data on file, last reported at $156.6 million in Q1 2026.

• Operating Expenses for Q1 2026 came in at $156.6 million, up 16.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $548.3 million (changed 0.1% YoY), and the FY2025 annual result was $512.8 million, down 3.93% from the prior year.
• Operating Expenses advanced to $156.6 million in Q1 2026 per TWST's latest filing, from $136.6 million in the prior quarter.
• Over five years, Operating Expenses peaked at $170.4 million in Q2 2024 and troughed at $98.9 million in Q4 2022.
• A 5-year average of $126.0 million and a median of $123.4 million in 2024 frame the typical range for Operating Expenses.
• The sharpest annual moves came in 2022 and 2025: Operating Expenses jumped 57.39% in 2022, then slipped 25.95% in 2025.
• A 5-year view of Operating Expenses shows it stood at $98.9 million in 2022, then gained by 19.83% to $118.5 million in 2023, then climbed by 4.12% to $123.4 million in 2024, then advanced by 10.73% to $136.6 million in 2025, then rose by 14.63% to $156.6 million in 2026.
• Business Quant data shows TWST's Operating Expenses at $156.6 million in Q1 2026, $136.6 million in Q4 2025, and $128.9 million in Q3 2025.